Skip to main content
. 2019 Dec 23;12:3925–3934. doi: 10.2147/IDR.S234211

Table 2.

Outcome Differences Between Carbapenem Combination Therapy and Colistin Monotherapy

Characteristics Combination Therapy (n = 83) Colistin Monotherapy (n = 77) P-value
Primary outcome
 14-day mortality 20 (24.1%) 16 (20.8%) 0.616
Secondary outcome
 In-hospital mortality 46 (55.4%) 29 (37.7%) 0.024
 Clinical improvement at day 14 47 (58.8%) 46 (73.1%) 0.076
 Negative conversion at day 14 34 (41.0%) 37 (48.7%) 0.328